Literature DB >> 10438634

Solution structure of the capsid protein from the human T-cell leukemia virus type-I.

S Khorasanizadeh1, R Campos-Olivas, M F Summers.   

Abstract

The solution structure of the capsid protein (CA) from the human T-cell leukemia virus type one (HTLV-I), a retrovirus that causes T-cell leukemia and HTLV-I-associated myelopathy in humans, has been determined by NMR methods. The protein consists of independent N and C-terminal domains connected by a flexible linker. The domains are structurally similar to the N-terminal "core" and C-terminal "dimerization" domains, respectively, of the human immunodeficiency virus type one (HIV-1) and equine infectious anemia virus (EIAV) capsid proteins, although several important differences exist. In particular, hydrophobic residues near the major homology region are partially buried in HTLV-I CA, which is monomeric in solution, whereas analogous residues in HIV-1 and EIAV CA project from the C-terminal domain and promote dimerization. These differences in the structure and oligomerization state of the proteins appear to be related to, and possibly controlled by, the oxidation state of conserved cysteine residues, which are reduced in HTLV-I CA but form a disulfide bond in the HIV-1 and EIAV CA crystal structures. The results are consistent with an oxidative capsid assembly mechanism, in which CA oligomerization or maturation is triggered by disulfide bo nd formation as the budding virus enters the oxidizing environment of the bloodstream. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438634     DOI: 10.1006/jmbi.1999.2986

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  54 in total

1.  Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.

Authors:  J B Bowzard; J W Wills; R C Craven
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy.

Authors:  S D Parker; J S Wall; E Hunter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Identification of the regions of Fv1 necessary for murine leukemia virus restriction.

Authors:  K N Bishop; M Bock; G Towers; J P Stoye
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein.

Authors:  L Dietrich; L S Ehrlich; T J LaGrassa; D Ebbets-Reed; C Carter
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly.

Authors:  Barbie K Ganser; Anchi Cheng; Wesley I Sundquist; Mark Yeager
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

6.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Retroviral capsid determinants of Fv1 NB and NR tropism.

Authors:  Anthony Stevens; Michael Bock; Scott Ellis; Paul LeTissier; Kate N Bishop; Melvyn W Yap; Willie Taylor; Jonathan P Stoye
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  In vitro assembly of virus-like particles of a gammaretrovirus, the murine leukemia virus XMRV.

Authors:  Romana Hadravová; Alex de Marco; Pavel Ulbrich; Jitka Stokrová; Michal Dolezal; Iva Pichová; Tomás Ruml; John A G Briggs; Michaela Rumlová
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

9.  Suppression of a morphogenic mutant in Rous sarcoma virus capsid protein by a second-site mutation: a cryoelectron tomography study.

Authors:  Carmen Butan; Parvez M Lokhandwala; John G Purdy; Giovanni Cardone; Rebecca C Craven; Alasdair C Steven
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

10.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.